CME Group (CME) Q2 FY2026 earnings: revenue $1.7 billion, up 0.8% on the year
CME Group Inc. (CME) reported revenue of $1.7 billion for Q2 FY2026, the quarter ended 30 June 2026, up 0.8% on the same quarter a year earlier. Net income was $1.0 billion, up 1.6% on the year, and diluted earnings per share $2.88. The figures are the company's own, from the 10-Q it filed with the SEC on 24 July 2026.
Revenue
$1.7 billion
+0.8% on the year · -9.2% on the quarter
Q3 FY2024Q2 FY2026
Operating margin
64.9%
66.7% a year earlier
Q3 FY2024Q2 FY2026
Net income
$1.0 billion
+1.6% on the year · -10.8% on the quarter
Q3 FY2024Q2 FY2026
Diluted EPS
$2.88
+2.5% on the year · -9.4% on the quarter
Q3 FY2024Q2 FY2026
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Revenue edged up, operating income fell: Revenue was $1,706.2 million against $1,692.0 million a year earlier. Operating income was $1,107.1 million against $1,129.3 million, while net income rose to $1,041.8 million from $1,025.1 million and GAAP diluted EPS was $2.88 against $2.81.
Adjusted operating income slipped, EPS rose: Adjusted operating income was $1,185.0 million against $1,200.8 million, and adjusted net income $1,081.7 million against $1,079.4 million. Adjusted diluted EPS was $2.99 against $2.96. Adjusted items are reconciled at the end of the release.
First half totals reached records: Six-month revenue was $3,586.3 million against $3,334.3 million, adjusted operating income $2,553.4 million against $2,368.5 million, and adjusted diluted EPS $6.35 against $5.75. The chairman tied the first-half figures to record Q1 trading.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q2 FY2026
Q1 FY2026
Q2 FY2025
On the quarter
On the year
Last 8 quarters
Operating cash flow
947
1,260
1,058
-24.8%
-10.5%
Capital expenditure
23.6
21.8
18.4
+8.3%
+28.3%
Free cash flow
924
1,238
1,040
-25.4%
-11.2%
Free cash flow margin
54.1%
65.9%
61.5%
Cash from investing
-29.4
-23.0
-18.0
Cash from financing
-8,091
2,116
20,999
Depreciation and amortisation
84.2
83.3
83.4
+1.1%
+1.0%
Share-based compensation
24.8
21.8
20.7
+13.8%
+19.8%
Dividends paid
468
2,698
455
-82.6%
+2.8%
Dividend per share
$1.30
$7.45
$1.25
-82.6%
+4.0%
Diluted shares, weighted
361m
363m
360m
-0.5%
+0.3%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q2 FY2026
Q1 FY2026
Q2 FY2025
On the quarter
On the year
Last 8 quarters
Shareholders' equity
26,520
26,618
27,739
-0.4%
-4.4%
Short-term borrowings
n/a
n/a
0.0
Debt
3,424
3,423
3,420
+0.0%
+0.1%
Operating lease liabilities
343
224
253
+53.0%
+35.5%
Finance lease liabilities
37.2
39.4
46.3
-5.6%
-19.7%
Other liabilities
164,352
171,688
148,448
-4.3%
+10.7%
Total liabilities and equity
194,677
201,994
179,907
-3.6%
+8.2%
Fixed assets
351
355
363
-1.2%
-3.2%
Goodwill
10,506
10,506
10,524
-0.0%
-0.2%
Intangible assets
2,045
2,551
2,728
-19.8%
-25.1%
Investments
131
124
118
+5.8%
+11.7%
Cash and equivalents
2,144
2,391
1,981
-10.3%
+8.2%
Receivables
753
936
668
-19.5%
+12.8%
Other assets
178,746
185,130
163,525
-3.4%
+9.3%
Total assets
194,677
201,994
179,907
-3.6%
+8.2%
Questions
What was CME Group's revenue in Q2 FY2026?
CME Group (CME) reported revenue of $1.7 billion for Q2 FY2026, the quarter ended 30 June 2026, up 0.8% on the same quarter a year earlier.
How much did CME Group earn in Q2 FY2026?
Net income for Q2 FY2026 was $1.0 billion, up 1.6% on the year, and diluted earnings per share $2.88.
When did CME Group report Q2 FY2026 results?
CME Group filed its 10-Q for the quarter ended 30 June 2026 with the SEC on 24 July 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 30 June 2026, filed 24 July 2026: the filing.